I have short reads from Illumia hiseq2000 (50bp, paired-end, DNAseq). I attached the figure of the distribution of quality scores from FastQC. It looks that the first 13 bases' quality scores are the same. So is this normal? I appreciate your help.
-
-
Every FastQC run I have done showed a distribution of quality scores at all points, even if it's a small distribution. So it looks weird to me.
You should probably check the scores. Make sure that they are not from an old pipeline (e.g. Illumina 1.3) since the encoding of quality scores was different. I'm guessing they might be, since it must be quite old data if it's 50bp reads. Otherwise I'm not sure what's happening. -
There's an orange flag at the sequence length distribution, which means that not all of your reads are 50bp. Have these fastq files already been cleaned?Comment
-
You could get this effect if a large proportion of your reads had the same quality score. With some of the newer HiC datasets we've occasionally seen bases where all of the percentiles fastqc plots are the same so you just get a line rather than seeing a distribution - this plot looks a little more extensive though. The more obvious reason (as kcchan suggested) is that you're looking at a filtered data file which would artificially create this situation.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment